Figure 1.

This figure illustrates the patient disposition during the course of the DB and OLE of DUET. Duration of treatment is defined as the time between the date of first sparsentan dose and either data cutoff date (ongoing patients) or date of last dose (discontinued patients). DB, double-blind; OLE, open-label extension.